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Standards of pancreaticoduodenectomy
in a tertiary referral centre in Hong
Kong: retrospective case series
Objective. To evaluate the perioperative outcomes of pancreaticoduodenectomy
in a tertiary referral centre in Hong Kong.
Design. Retrospective case series.
Setting. University teaching hospital, Hong Kong.
Patients. One hundred and forty patients who underwent pancreaticoduo-
denectomy from July 1989 through June 2001.
Main outcome measures. Mortality and morbidity.
Results. Overall hospital mortality among 140 patients was 2.9% (n=4), and 30-
day operative mortality was 2.1% (n=3). There was no significant difference in
the hospital mortality rate between 43 elderly patients aged 70 years or older and
97 younger patients (2.3% versus 3.1%). The overall morbidity rate was 38.6%
(n=54). Intra-abdominal abscess (13.6%) and pancreaticojejunal anastomotic
leakage (12.9%) were the two most common complications. Presence of co-
morbid illness (risk ratio, 2.823; 95% confidence interval, 1.541-4.385; P=0.01),
preoperative cholangitis (risk ratio, 2.565; 95% confidence interval, 1.166-5.643;
P=0.02), and intra-operative blood loss ≥1.5 L (risk ratio, 2.236; 95%
confidence interval, 1.132-6.213; P=0.03) were independent risk factors for post-
operative morbidity.
Conclusions. Pancreaticoduodenectomy is associated with a low risk of opera-
tive death when performed in a tertiary referral setting in Hong Kong. The post-
operative morbidity rate remains high, however. Further improvement by reducing
intra-operative blood loss may help curtail the high postoperative morbidity.
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Introduction
Pancreaticoduodenectomy is one of the most complex surgical procedures, and
is associated with substantial operative mortality and morbidity rates. The first
successful pancreaticoduodenectomy was performed by the German surgeon,
Kausch, in 1912,1 and the operation was popularised in 1935 by Whipple et al,2
who reported three cases of pancreaticoduodenal resection. Until the 1980s, the
operative mortality rate of pancreaticoduodenectomy was 20% to 25%, and at
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one time some surgeons even proposed that this operation
should be completely abandoned as a treatment for carcin-
oma of the head of the pancreas.3,4 A comprehensive review
of the literature that included 1859 patients who underwent
pancreatic resection for pancreatic cancer between 1980
and 1986 showed a mortality rate of 16%, which was
unacceptably high when compared with other types
of elective surgery.5 In the 1990s, several major centres in
western countries reported dramatically reduced operative
mortality rates as a result of improved surgical management
and increased experience.6-14 Several studies have linked
the improved operative outcomes after pancreaticoduo-
denectomy in the 1990s with concentration of case volume
in tertiary referral centres.8-11,13,14 While an operative or in-
hospital mortality rate of less than 5% had been achieved
in high-volume centres, mortality rates in low-volume hos-
pitals were still in the range of 13% to 20% in the 1990s.8-11,13,14
In centres with a case volume of more than 40 per year, a
mortality rate of less than 2% has been reported.7,12
The most common indication for pancreaticoduo-
denectomy is carcinoma of the head of pancreas.7,11,12 With
the improved safety of pancreaticoduodenectomy, the
operation is also considered an appropriate treatment for
selected patients with chronic pancreatitis, which constitutes
the second most common indication for the operation in
western series.7,12 Pancreatic cancer is much less common
in Hong Kong than in western countries. It is the fourth
leading cause of cancer death in men and the fifth leading
cause in women in the US,15 whereas in Hong Kong, it only
ranks 16th in cancer incidence.16 Chronic pancreatitis due
to alcoholism is also much less prevalent among the local
population compared with western populations. Hence,
the experience of pancreaticoduodenectomy among local in-
stitutions is expected to be low compared with western centres.
It is unknown whether the current standards of pancreaticoduo-
denectomy in Hong Kong are on a par with western centres.
This study evaluated the perioperative outcomes of 140
patients who underwent pancreaticoduodenectomy in a
local tertiary referral centre during a 12-year period.
Methods
Between July 1989 and June 2001, 140 patients underwent
elective pancreaticoduodenectomy at the Department
of Surgery of the University of Hong Kong in Queen
Mary Hospital. All patients were operated and managed
by a team of surgeons specialised in hepatobiliary and
pancreatic surgery. A retrospective study was performed by
reviewing the records of these patients for clinical,
laboratory, operative, and pathological data. Any post-
operative complications and mortality were documented.
Operative mortality was defined as death within 30 days of
surgery, and hospital mortality was defined as any death
that occurred during the admission for surgery.
All continuous variables were expressed as a mean and
standard deviation (SD) and compared using the Student’s t
test. Categorical variables were compared using the Chi
squared test with Yates’ correction or Fisher’s exact test
where appropriate. Univariate analysis was performed to
evaluate the impact of 12 clinical and operative parameters
on postoperative morbidity and mortality, including age, sex,
any co-morbid illness, preoperative cholangitis, preoperative
biliary drainage, preoperative serum bilirubin level, pre-
operative serum albumin level, nature of disease (malignant
versus benign), type of operation (conventional versus
pylorus-preserving pancreaticoduodenectomy), any portal
vein resection, operative blood loss, and any perioperative
transfusion. Multivariate analysis was performed by logis-
tic regression analysis. Statistical analysis was performed
using statistical software (Statistical Package for the
Social Sciences; Windows 9.0; SPSS Inc., Chicago, US).
A P value <0.05 was considered statistically significant.
Results
Patients included 85 men and 55 women, with a mean age
of 61.7 years (range, 16-91 years; SD, 13.1 years). There
were 43 (30.7%) elderly patients aged 70 years or older.
Fifty-nine (42.1%) patients had one or more chronic co-
morbid illnesses, which included cardiovascular disease
(n=32), chronic respiratory disease (n=10), and diabetes
mellitus (n=28). Preoperative biliary drainage was performed
in 77 (55.0%) patients, either by endoscopic stenting (n=50)
or percutaneous transhepatic biliary drainage (n=27). Ninety-
seven (69.3%) patients underwent conventional Whipple’s
operation, whereas the other 43 (30.7%) patients underwent
pylorus-preserving pancreaticoduodenectomy. Concomitant
procedures included portal vein resection for six patients
and hepatic resection for two patients. The mean duration
of operation was 8.6 hours (range, 5.5-15.0 hours; SD, 2.4
hours). The pathological diagnoses of the 140 patients are
depicted in Table 1.
Postoperative mortality
Overall there were four (2.9%) hospital deaths, three after
pancreaticoduodenectomy alone (two for carcinoma of the
head of the pancreas and one for chronic pancreatitis) and
one after pancreaticoduodenectomy combined with right
extended hepatectomy for a carcinoma of the bile duct
extending into the right hepatic duct. The precipitating causes
of death were intra-abdominal sepsis without anasto-
motic leakage (n=1), intra-abdominal sepsis secondary to
Table 1. Pathological diagnoses of 140 patients who under-
went pancreaticoduodenectomy
Pathology Patients No. (%)
Malignant
Carcinoma of pancreas 60 (42.9)
Carcinoma of ampulla 40 (28.6)
Carcinoma of bile duct 18 (12.9)
Carcinoma of duodenum 3 (2.1)
Benign
Chronic pancreatitis 11 (7.9)
Tuberculosis of pancreas* 2 (1.4)
Adenoma of ampulla 6 (4.3)
* Preoperative diagnosis was pancreatic carcinoma in both cases
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pancreaticojejunostomy leakage (n=1), acute myocardial in-
farction (n=1), and massive gastrointestinal haemorrhage
(n=1). There were no hospital deaths among the six patients
with portal vein resection. Three of the four hospital deaths
occurred within 30 days after surgery, giving a 2.1% opera-
tive mortality rate. Dividing the study period into two halves
between July 1989 to June 1995 (n=48) and July 1995 to
July 2001 (n=92), the hospital mortality rate has been
reduced from 4.2% (n=2) in the early half of the study
period to 2.2% (n=2) in the latter half, but the difference
was not statistically significant.
Table 2 shows comparisons of the hospital mortality
rates between subgroups categorised by the aforementioned
clinical and operative parameters. None of the parameters
had a significant impact on the hospital mortality rate
by univariate analysis, except that there was a trend towards
a higher hospital mortality rate in patients with intra-
operative blood loss ≥1.5 L compared with those with less
blood loss (7.5% versus 1.0%; P=0.07). It is noteworthy
that the hospital mortality rate in the 43 elderly patients aged
70 years or older was not significantly higher than that of
the 97 younger patients (2.3% versus 3.1%).
Postoperative morbidity
Complications were encountered in 54 (38.6%) of the 140
patients (Table 3). The two most common complications
were intra-abdominal abscess (13.6%) and leakage of
pancreaticojejunal anastomosis (12.9%). Table 4 shows
the results of univariate analysis of risk factors for post-
operative morbidity. Male sex, presence of co-morbid
illness, preoperative cholangitis, pylorus-preserving
pancreaticoduodenectomy, intra-operative blood loss
≥1.5 L, and perioperative blood transfusion were associ-
ated with significantly increased morbidity. On multivariate
analysis, the presence of co-morbid illness (risk ratio [RR],
2.823; 95% confidence interval [CI], 1.541-4.385; P=0.01),
preoperative cholangitis (RR, 2.565; 95% CI, 1.166-5.643;
P=0.02), and intra-operative blood loss ≥1.5 L (RR, 2.236;
95% CI, 1.132-6.213; P=0.03) were independent risk
factors for postoperative morbidity.
Discussion
Pancreaticoduodenectomy is a surgical procedure that has
been widely studied with respect to its perioperative out-
comes during the past decade, but data in the literature are
derived mainly from western centres.6-9,12 The concentration
of patients undergoing the procedure in tertiary referral
centres is considered an important factor for the low opera-
tive mortality rate observed in recent western studies. In
fact, several studies have demonstrated a significant impact
of hospital volume on the perioperative outcomes after
pancreaticoduodenectomy.8-11,13,14 Based on the western
experience, an overseas panel of experts have recommended
concentration of major surgical procedures such as
pancreaticoduodenectomy in high-volume hospitals in a
recent review of surgical services in Hong Kong.17 However,
there is a paucity of data on the results of pancreaticoduo-
denectomy in Hong Kong, which may not be comparable
with that of western centres in view of the much smaller
volume of patients undergoing this operation in local
institutions. Hence, a retrospective study was performed
to evaluate the standards of this operation in a tertiary
Table 2. Hospital mortality according to preoperative and operative factors
Factor Hospital deaths P value
No. (%)
Age <70 years (n=97) 3 (3.1) 0.64
≥70 years (n=43) 1 (2.3)
Sex Male (n=85) 3 (3.5) 0.49
Female (n=55) 1 (1.8)
Co-morbid illness No (n=81) 2 (2.5) 0.65
Yes (n=59) 2 (3.4)
Preoperative cholangitis No (n=129) 4 (3.1) 0.72
Yes (n=11)* 0 (0)
Preoperative biliary drainage No (n=63) 2 (3.2) 0.66
Yes (n=77) 2 (2.6)
Nature of disease Benign (n=19) 1 (5.3) 0.47
Malignant (n=121) 3 (2.5)
Preoperative bilirubin <50 mmol/L (n=66) 2 (3.0) 0.69
≥50 mmol/L (n=74) 2 (2.7)
Preoperative albumin <40 g/L (n=65) 2 (3.1) 0.66
≥40 g/L (n=75) 2 (2.7)
Operation Conventional PD† (n=97) 4 (4.1) 0.31
Pylorus-preserving PD (n=43) 0 (0)
Portal vein resection No (n=134) 4 (3.0) 0.84
Yes (n=6) 0 (0)
Operative blood loss <1.5 L (n=100) 1 (1.0) 0.07
≥1.5 L (n=40) 3 (7.5)
Perioperative transfusion No (n=85) 1 (1.2) 0.13
Yes (n=55) 3 (5.5)
* Includes eight patients who initially presented with cholangitis and three patients who developed cholangitis as a result of a blocked stent
† PD pancreaticoduodenectomy
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referral centre in Hong Kong. Furthermore, with an aim of
improving the operative results, we also analysed the factors
that may influence mortality or morbidity after the operation.
The hospital mortality rate for this series of 140 patients
operated during a 12-year period was 2.9%. The average
case volume per year in our institution during the study
period was 12 per year, but the case volume has increased
from eight cases per year in the first 6 years to 15 per year
in the final 6 years. In a study of the results of pancreatico-
duodenectomy in 39 hospitals in the US, low-, medium-,
and high-volume centres for pancreaticoduodenectomy
were defined as 1 to 5 cases per year, 6 to 20 cases per year,
and more than 20 cases per year, respectively, and the
corresponding hospital mortality rates were 19%, 12%, and
2.2%, respectively.9 Other recent western studies using
similar definitions have reported similar mortality rates in
hospitals with different volumes of pancreatic resection.10,18
Our institution would be classified as a medium-volume
centre according to such definition, but our hospital mortal-
ity rate was comparable to those of high-volume western
centres.9,10,14 The largest single-institution experience of
pancreaticoduodenectomy reported thus far in the literature
was from a centre with 650 cases of pancreaticoduo-
denectomy between 1990 and 1996 (ie >100 cases per year),
and the hospital mortality rate in that series was 1.4%.12
The mortality rate in our centre was slightly higher, but the
difference was not remarkable.
The low hospital mortality rate observed in our experi-
ence is likely to be related to the management of all patients
by a specialised team of hepatobiliary and pancreatic
surgeons, even though the case volume was not high com-
pared with western standards. A recent study in the UK has
demonstrated significantly lower postoperative mortality rate
after resection of pancreatic and periampullary tumours in
specialist pancreatic units compared with general surgical
units (average mortality rate 4.9% versus 9.8%).11 A ter-
tiary referral centre is likely to offer better facilities and
expertise in perioperative care, such as more sophisticated
diagnostic imaging and radiological interventions, special-
ised anaesthetic services, and a well-equipped intensive
care unit. However, the experience of the surgical team is of
equal, if not more, importance when a complex operation is
Table 3. Complications of 140 patients who underwent
pancreaticoduodenectomy
Complication Patients*
No. (%)
Cardiac complications 5 (3.6)
  (arrhythmia, myocardial infarction)
Chest infection 15 (10.7)
Gastrointestinal bleeding 5 (3.6)
Wound infection 15 (10.7)
Intra-abdominal abscess 19 (13.6)
Pancreaticojejunostomy leakage 18 (12.9)
Hepaticojejunostomy leakage 2 (1.4)
Postoperative haemorrhage 3 (2.1)
Delayed gastric emptying (>7 days) 13 (9.3)
Any complication 54 (38.6)
* Some patients had more than one complication
Table 4. Morbidity according to preoperative and operative factors
Factor Patients P value
No. (%)
Age <70 years (n=97) 37 (38.1) 0.88
≥70 years (n=43) 17 (39.5)
Sex Male (n=85) 39 (45.9) 0.03
Female (n=55) 15 (27.3)
Co-morbid illness No (n=81) 22 (27.2) 0.004
Yes (n=59) 32 (54.2)
Preoperative cholangitis No (n=129) 46 (35.7) 0.02
Yes (n=11)* 8 (72.7)
Preoperative biliary drainage† No (n=63) 25 (39.7) 0.81
Yes (n=77) 29 (37.7)
Nature of disease Benign (n=19) 10 (52.6) 0.18
Malignant (n=121) 44 (36.4)
Preoperative bilirubin <50 mmol/L (n=66) 25 (37.9) 0.72
≥50 mmol/L (n=74) 29 (39.2)
Preoperative albumin <40 g/L (n=65) 28 (43.1) 0.36
≥40 g/L (n=75) 26 (34.7)
Operation Conventional PD‡ (n=97) 31 (32.0) 0.02
Pylorus-preserving PD (n=43) 23 (53.5)
Portal vein resection No (n=134) 51 (38.1) 0.88
Yes (n=6) 3 (50.0)
Operative blood loss <1.5 L (n=100) 31 (31.0) 0.01
≥1.5 L (n=40) 23 (57.5)
Perioperative transfusion No (n=85) 27 (31.8) 0.04
Yes (n=55) 27 (49.1)
* Includes eight patients who initially presented with cholangitis and three patients who developed cholangitis as a result of a blocked stent
† No significant difference between patients without preoperative biliary drainage and patients with preoperative biliary drainage in wound infection rate (7.9% vs
12.9%; P=0.30) or intra-abdominal abscess (12.7% vs 14.3%; P=0.68)
‡ PD pancreaticoduodenectomy
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being performed only once a month or less frequently. It is
not only the operative technique but also the perioperative
management that determine patients’ outcomes. In a
recent study, hospital rather than individual surgeon’s case
volume was identified as the most important determinant
of hospital mortality rate after resection of pancreatic
cancer.18 The authors suggested that the combined ‘experi-
ence effect’ of the whole team of surgeons is more import-
ant than the number of operations performed by a particular
surgeon, and the development of a systematic approach in
perioperative management by a specialised team may be an
important factor for better perioperative outcomes.18
The low operative mortality rate in this study, together
with the data from western studies regarding the impact of
hospital volume on perioperative outcomes, seem to sup-
port the concentration of complex surgical procedures such
as pancreaticoduodenectomy in tertiary referral centres in
Hong Kong. However, without a study that compares the
operative outcomes of pancreaticoduodenectomy between
tertiary referral centres and general surgical units in Hong
Kong, it is impossible to draw a conclusion. The influence
of any confounding factors such as patient characteristics
that may affect operative results in different institutions needs
to be adjusted in such a study.
Except for a trend towards a higher hospital mortality
rate with excessive operative blood loss, no significant
factors were found to affect the mortality rate in this study.
A previous study of 13 deaths among 221 patients with
pancreaticoduodenectomy found that operative blood loss
was a significant risk factor for postoperative mortality.19
The overall mortality rate in our series was so low that it is
unlikely to yield any statistically significant risk factor with
such an analysis. However, some of the results of the analy-
sis do carry certain implications. The hospital mortality rate
of elderly patients aged 70 years or older was similar to
that of younger patients. This finding is in accordance with
previous studies of oesophagectomy and hepatectomy in
elderly patients in our institution.20,21 The oldest patient who
underwent pancreaticoduodenectomy in this series was a
91-year-old man, who recovered without any complications.
Our results indicate that advanced age alone should not be
considered a contraindication for pancreaticoduodenectomy.
This finding has an important implication for the selection
of patients for pancreaticoduodenectomy at a time when
surgeons are faced with an increasing number of elderly
patients in the Hong Kong population. Of course, the im-
portance of careful preoperative assessment and meticulous
postoperative management of elderly patients cannot be
overemphasised. No mortality was observed in the six cases
of pancreaticoduodenectomy with portal vein resection, which
was indicated because of tumour involvement. Studies in the
early 1990s reported high mortality rates (6%-17%) and poor
survival results with portal vein resection in pancreatic
cancer.22-24 However, more recent studies have found no sig-
nificant difference in the operative mortality rate or long-term
survival between patients who did and those who did not
undergo portal vein or superior mesenteric vein resection for
tumour involvement.25,26 Although experience in our centre
with portal vein resection is limited, the authors believe that
pancreatic carcinoma with isolated portal vein involvement
should not be considered a contraindication to surgery.27
While the operative mortality rate in this series was low,
the operative morbidity rate (38.6%) was high. Our experi-
ence is comparable with that of western centres, which
reported morbidity rates of approximately 40% after
pancreaticoduodenectomy despite remarkably reduced
mortality rates in recent years.6,7,12,28 Leakage of pancreatico-
enteric anastomosis was one of the most common com-
plications in this study, with an incidence of 12.6%.
Pancreatic leakage rates of 10% to 20% after pancreaticoduo-
denectomy have been reported in major western centres,
and have not declined significantly in the past 30 years.28
Despite intensive effort by pancreatic surgeons to prevent
pancreatic anastomotic leakage through modification of
surgical techniques or use of prophylactic octreotide, none
of the measures have thus far been proved to be effective in
reducing the pancreatic leakage rate.29 Pancreatic leakage
is a potentially serious complication that can lead to intra-
abdominal sepsis and haemorrhage, and it has been associ-
ated with a mortality rate of 20% to 40% in the past.30 The
high morbidity rate but low mortality rate in this study
indicates that successful management of postoperative com-
plications such as pancreatic anastomotic leakage and
intra-abdominal abscess plays an important role in achiev-
ing the low mortality. The concerted efforts of the surgeons,
intensive care staff, interventional radiologists, and clinical
microbiologists in the management of postoperative com-
plications are critical to the favourable mortality outcome.
Further improvement in the operative results of
pancreaticoduodenectomy relies on measures to reduce
postoperative morbidity. Analysis of risk factors of mor-
bidity revealed that the presence of co-morbid illness,
preoperative cholangitis, and excessive blood loss were
independent factors related to increased morbidity. The
morbidity rate was similar between elderly and younger
patients. Hence, it is the presence of co-morbid illness rather
than age alone that determines postoperative outcome.
Better preparation of patients with co-morbid illnesses and
vigilant postoperative care may help reduce morbidity, but
complications should be anticipated and managed in a timely
fashion in such patients to avoid mortality. Patients who
presented with cholangitis may have colonisation of
bacteria in the bile even after control of sepsis, and thus are
at risk of postoperative intra-abdominal sepsis. This is a non-
preventable risk factor, but adequate preoperative biliary
drainage and use of prophylactic antibiotics may help
minimise postoperative complications in such patients. For
patients with jaundice but without cholangitis, the role of
preoperative biliary drainage is more controversial. The
data in this study indicated that neither preoperative biliary
drainage nor preoperative bilirubin level was a risk factor
for postoperative morbidity. Based on retrospective studies,
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some authors have reported increased postoperative
morbidity and mortality after pancreaticoduodenectomy
in patients with preoperative biliary drainage,31 but others
have not observed increased morbidity associated with
preoperative biliary drainage.32,33 The role of biliary drain-
age for jaundiced patients before pancreaticoduodenectomy
needs to be evaluated with a prospective randomised study.
Reduction of operative blood loss by meticulous surgical
techniques is probably the most practical measure that
surgeons can employ to reduce postoperative morbidity.
Other authors have demonstrated that operative blood loss
is a major risk factor for complications after pancreatico-
duodenectomy.19 Excessive blood loss increases surgical
stress and also entails the need for blood transfusion, both
of which have been shown to exert an immunosuppressive
effect and to increase postoperative morbidity, especially
septic complications.34,35
Conclusion
This study shows that pancreaticoduodenectomy can be
performed with a low mortality rate in a tertiary referral
centre in Hong Kong. When performed by a specialised team
of surgeons, the perioperative results were comparable
to those reported from well-established western centres,
despite a lower case volume due to a lower prevalence of
pancreatic cancer and chronic pancreatitis in the local
population. However, operative morbidity could be
improved.  Further reduction in intra-operative blood
loss by meticulous surgical techniques may be an effective
measure to reduce morbidity.
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